Moore, Ph.D., from The University of Texas Health Science Center in Austin, and colleagues examined the impact of fetal exposure to cannabis on adiposity and glucose-insulin traits in early life in a subsample of 103 mother-child pairs.
The researchers found that about 15 percent of the women had detectable levels of any cannabinoid, indicative of fetal cannabis exposure.